Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study.
Severe, Highly Active, or Aggressive Multiple Sclerosis.
Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.
Primary Sjögren Syndrome in a Child with a Neuromyelitis Optica Spectrum Disorder.
A Hedonism Hub in the Human Brain.
Nodo-paranodopathy, internodopathy and cleftopathy: Target-based reclassification of Guillain-Barré-like immune-mediated polyradiculoneuropathies in dogs and cats.
Immune cell-specific transcriptional profiling highlights distinct molecular pathways controlled by Tob1 upon experimental autoimmune encephalomyelitis.
Transcriptomic analyses of genes and tissues in inherited sensory neuropathies.
An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol.
Effect of fampridine on axonal excitability in multiple sclerosis.
Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals.
The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.
Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development.
Modulation of sphingosine receptors influences circadian pattern of cardiac autonomic regulation.
[MEDICAL CANNABIS].
Increased structural white and grey matter network connectivity compensates for functional decline in early multiple sclerosis.
Walk them or no leg to stand on! Diagnostic delay of neurologic conditions in young children.
Qualitative perspectives on aquatic exercise initiation and satisfaction among persons with multiple sclerosis.
High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.
Yoga research review.
Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
Osmotic demyelination syndrome after slow sodium administration in a hyponatremic patient with concurrent hypokalemia.
Pages
« first
‹ previous
…
698
699
700
701
702
703
704
705
706
…
next ›
last »